JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: Combretastatin A4 (CA-4; CRC-87-09) is a highly potent tubulin inhibitor with potential antitumor activity. It belongs to the so called microtubule-targeting agent (MTA) or microtubule disrupting agent and acts by binding to beta-tubulin with a Kd of 0.4 uM.
References: J Med Chem. 2014 Apr 24; 57(8):3369-81; Magn Reson Med. 2016 Feb; 75(2):866-72.
Publications Citing Use of InvivoChem Combretastatin A4 (CA-4; CRC 87-09):
1) Eur J Med Chem. 2019 Dec 15; 184:111732. doi: 10.1016/j.ejmech.2019.111732;
2) Eur J Med Chem. 2021 Mar 5; 213:113058. doi: 10.1016/j.ejmech.2020.113058.
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!